ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is NeuPath Health, Inc. ?
1
The company has declared positive results in Mar'2026 after 2 consecutive negative quarters
- NET PROFIT(Q) At CAD 0.48 MM has Grown at 321.06%
- ROCE(HY) Highest at 0.04%
- PRE-TAX PROFIT(Q) At CAD 0.68 MM has Grown at 136.63%
2
With ROE of 4.30%, it has a fair valuation with a 1.50 Price to Book Value
- Over the past year, while the stock has generated a return of 137.74%, its profits have risen by 89%
3
Market Beating Performance
- The stock has generated a return of 137.74% in the last 1 year, much higher than market (S&P/TSX 60) returns of 28.02%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to NeuPath Health, Inc. should be less than 10%
- Overall Portfolio exposure to Finance should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NeuPath Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
NeuPath Health, Inc.
93.33%
3.73
57.71%
S&P/TSX 60
20.36%
2.23
12.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.21%
EBIT Growth (5y)
31.88%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.28%
ROE (avg)
0.16%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
1.50
EV to EBIT
14.38
EV to EBITDA
7.51
EV to Capital Employed
1.43
EV to Sales
0.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.93%
ROE (Latest)
4.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CAD 3.41 MM
ROCE(HY)
Highest at 6.06%
PRE-TAX PROFIT(Q)
At CAD 0.84 MM has Grown at 103.26%
NET PROFIT(Q)
Highest at CAD 1.62 MM
EPS(Q)
Highest at CAD 0.03
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 5.44% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 42.05 %
Here's what is working for NeuPath Health, Inc.
Net Profit
At CAD 1.62 MM has Grown at 2,072.81%
over average net sales of the previous four periods of CAD -0.08 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CAD MM)
Operating Cash Flow
Highest at CAD 3.41 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Pre-Tax Profit
At CAD 0.84 MM has Grown at 103.26%
over average net sales of the previous four periods of CAD 0.41 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 1.62 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
EPS
Highest at CAD 0.03
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CAD)
Here's what is not working for NeuPath Health, Inc.
Debt-Equity Ratio
Highest at 42.05 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
